Evidence map›Paper›PMID 36510317›Full record

ArticleReproductive biology and endocrinology : RB&E2022

MiR-145 is upregulated in the retarded preimplantation embryos and modulates cholesterol levels in mice preimplantation embryos through targeting Abca1.

Ou Jian, Ni MengXia, Xing Shiyu, Meng QingXia, Zou QinYan, Ding Jie, Wang Wei, Wan Jiaojiao, Li Hong, Huang Yining

Open access · goldAbstract read
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ou Jian *Center for Reproduction and Genetics, Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Ni MengXia *Center for Reproduction and Genetics, Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Xing ShiyuCenter for Reproduction and Genetics, Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Meng QingXiaCenter for Reproduction and Genetics, Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Zou QinYanCenter for Reproduction and Genetics, Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Ding JieCenter for Reproduction and Genetics, Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Wang WeiCenter for Reproduction and Genetics, Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Wan JiaojiaoPeking Jabrehoo Med-Tech Co., Ltd, No. 19 Tianrong Road, Daxing Bio-medicine Industry Park, Daxing District, Peking, 102629, China.
Li HongCenter for Reproduction and Genetics, Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China. hongliszivf@163.com.
Huang YiningPeking Jabrehoo Med-Tech Co., Ltd, No. 19 Tianrong Road, Daxing Bio-medicine Industry Park, Daxing District, Peking, 102629, China. yininghuang@hotmail.com.
Suzhou Municipal Hospital · CNNanjing Medical University · CN

Funding

Industrial Technology Innovation Project of Suzhou City SYS201566Suzhou Introduced Project of Clinical Medical Expert Team LCZX202109Suzhou Introduce Expert Team of Clinical Medicine SZYJTD201708Suzhou key clinical diseases funding LCZX202109
6 · The paper itself

Abstract

backgroundPreimplantation embryonic lethality is a driver of female infertility. Certain microRNAs (miRNAs) have previously been demonstrated to play important roles in the regulation of embryogenesis.

methodsNormally developing blastocysts and arrested embryos were collected from patients undergoing intracytoplasmic sperm injection (ICSI), and the expression of specific miRNAs therein was evaluated by qPCR. The overexpression of target molecule miR-145 in early mice embryos was achieved via oocyte microinjection, enabling the subsequent monitoring of how such overexpression impacted embryonic development. Bioinformatics approaches were utilized to identify putative miR-145 target mRNAs, and luciferase reporter assessments were implemented to confirm the ability of miR-145 to regulate Abca1 in HEK293T cells. The functional relationship between miR-145 and Abca1 in the mice's embryonic development was then confirmed through rescue assays.

resultsAbnormally increased miR-145 expression was observed in patients' arrested embryos, and the exogenous overexpression of this miRNA significantly suppressed mural blastocyst formation. Mechanistically, miR-145 was found to bind to the 3'-untranslated area of the Abca1 mRNA in HK293T cells, thus suppressing its expression and increasing embryonic cholesterol levels. In line with the importance of these cholesterol levels to embryogenesis, the upregulation of Abca1 was sufficient to rescue the observed change in cholesterol levels and the associated retardation of mice embryonic development that occurred in response to the overexpression of miR-145.

conclusionThe regulatory dynamics of the miR-145/Abca1 axis play an important role in shaping normal embryonic development.

Indexed as

ATP Binding Cassette Transporter 1CholesterolEmbryo, MammalianMicroRNAsAnimalsBlastocystFemaleHEK293 CellsHumansMaleMiceRNA, MessengerABCA1 protein, humanAbca1 protein, mouseATP Binding Cassette Transporter 1CholesterolMicroRNAsMIRN145 microRNA, humanRNA, MessengerAbca1CholesterolICSImiR-145Preimplantation embryonic lethality

Identifiers

PMID36510317
PMCPMC9743540
OpenAlexW4312019046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.